1. Advances in cancer therapy with radiolabeled monoclonal antibodies;Goldenberg;Q J Nucl Med Mol Imaging.,2006
2. Radioimmunotherapy, a new breakthrough in the treatment of follicular non-Hodgkin's lymphoma: the European perspective;Chatal;Cancer Biother Radiopharm.,2006
3. Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody;Goldenberg;J Clin Oncol.,1991
4. Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody;Juweid;Cancer Res.,1995
5. Pharmacokinetics, dosimetry and initial therapeutic results with 131I- and 111In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed/refractory non-Hodgkin's lymphoma (NHL);Juweid;Clin Cancer Res.,1999